 | This redirect does not require a rating on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
 | The following Wikipedia contributor may be personally or professionally connected to the subject of this article. Relevant policies and guidelines may include conflict of interest, autobiography, and neutral point of view. |
 | The contents of the Multitarget stool DNA screening test page were merged into Stool test. For the contribution history and old versions of the merged article please see its history. |
Funded contribution
editAcknowledgment: The initial content for this entry was developed and uploaded by Sam Zastrow, Exact Sciences Wikipedian. Questions about the content can be directed to [email protected]. The initial content is consistent with the US Food and Drug Administration labeling for Cologuard on November 12, 2015. Editorial and writing assistance were provided by Evidence Scientific Solutions and was funded by Exact Sciences. — Preceding unsigned comment added by Sszastrow (talk • contribs) 19:43, 12 November 2015
Controversy over $502 pricing and false positives
editMayo spins rosy tale on Cologuard cancer screen — ignoring costs, false-positives and other crucial context http://www.healthnewsreview.org/2015/11/mayo-spins-rosy-tale-on-cologuard-cancer-screen/
High Price Tag for Cologuard Confirmed, but Test Is Welcomed http://www.medscape.com/viewarticle/835506
— Preceding unsigned comment added by Ocdcntx23:15, 3 January 2016 (talk • contribs)